Financials AXA

Equities

CS

FR0000120628

Life & Health Insurance

Real-time Euronext Paris 08:46:27 2023-12-04 am EST Intraday chart for AXA 5-day change 1st Jan Change
28.94 EUR +0.16% +2.05% +11.07%

Valuation

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 44 946 60 384 46 637 62 576 62 187 63 137 - -
Enterprise Value (EV) 1 29 589 51 536 90 842 59 292 94 301 76 312 76 312 76 312
P/E ratio 23,9x 16,6x 15,6x 8,82x 9,21x 8,65x 7,86x 7,30x
Yield 7,11% 5,69% 7,33% 5,88% 6,52% 6,43% 6,91% 7,45%
Capitalization / Revenue 0,44x 0,58x 0,48x 0,63x 0,61x 0,79x 0,71x 0,65x
EV / Revenue 0,29x 0,50x 0,94x 0,59x 0,92x 0,95x 0,86x 0,78x
EV / EBITDA - - - - - - - -
EV / FCF 4,48x 6,14x 3,61x 9,60x 12,5x 14,7x 13,6x 12,7x
FCF Yield 22,3% 16,3% 27,7% 10,4% 7,98% 6,81% 7,34% 7,86%
Price to Book 0,72x 0,86x 0,65x 0,96x 1,49x 1,38x 1,28x 1,19x
Nbr of stocks (in thousands) 2 383 366 2 404 779 2 390 174 2 389 774 2 386 757 2 185 051 - -
Reference price 2 18,9 25,1 19,5 26,2 26,1 28,9 28,9 28,9
Announcement Date 21/02/19 20/02/20 25/02/21 24/02/22 23/02/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 102 874 103 532 96 723 99 931 102 345 79 946 88 795 97 240
EBITDA - - - - - - - -
EBIT 1 4 738 5 841 4 264 9 514 9 329 7 665 8 763 9 408
Operating Margin 4,61% 5,64% 4,41% 9,52% 9,12% 9,59% 9,87% 9,68%
Earnings before Tax (EBT) 1 4 462 5 014 4 872 9 196 8 710 9 394 9 691 10 235
Net income 1 2 140 3 860 3 164 7 294 6 675 7 512 8 163 8 610
Net margin 2,08% 3,73% 3,27% 7,30% 6,52% 9,40% 9,19% 8,85%
EPS 2 0,79 1,51 1,25 2,97 2,83 3,34 3,68 3,96
Free Cash Flow 1 6 600 8 399 25 145 6 176 7 528 5 200 5 600 6 000
FCF margin 6,42% 8,11% 26,0% 6,18% 7,36% 6,50% 6,31% 6,17%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 308% 218% 795% 84,7% 113% 69,2% 68,6% 69,7%
Dividend per Share 2 1,34 1,43 1,43 1,54 1,70 1,86 2,00 2,15
Announcement Date 21/02/19 20/02/20 25/02/21 24/02/22 23/02/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period : December 2019 S1 2020 S1 2021 Q1 2021 S1 2021 S2 2022 Q1 2022 S1 2022 S2 2023 S1
Net sales 1 57 949 52 391 30 486 53 865 46 066 23 294 55 141 47 204 40 715
EBITDA - - - - - - - - -
EBIT 3 620 1 885 - - - - - - -
Operating Margin 6,25% 3,60% - - - - - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income 2 333 1 429 - 3 996 - - 4 108 2 567 3 833
Net margin 4,03% 2,73% - 7,42% - - 7,45% 5,44% 9,41%
EPS 0,92 0,56 - 1,63 1,34 - 1,73 1,10 -
Dividend per Share - - - - - - - - -
Announcement Date 01/08/19 06/08/20 02/05/21 02/08/21 24/02/22 03/05/22 03/08/22 23/02/23 03/08/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - 44 205 - 32 114 13 175 13 175 13 175
Net Cash position 1 15 357 8 848 - 3 284 - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 6 600 8 399 25 145 6 176 7 528 5 200 5 600 6 000
ROE (net income / shareholders' equity) 3,24% 5,83% 4,47% 14,7% 12,8% 15,6% 16,4% 15,8%
Shareholders' equity 1 66 005 66 163 70 754 49 619 52 148 48 023 49 636 54 626
ROA (Net income/ Total Assets) 0,24% 0,45% 0,58% 0,86% 0,99% 1,00% 1,15% 1,16%
Assets 1 900 105 855 686 545 029 852 202 676 408 751 217 711 721 741 318
Book Value Per Share 2 26,2 29,3 30,0 27,4 17,5 21,0 22,5 24,2
Cash Flow per Share - - 10,7 - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 21/02/19 20/02/20 25/02/21 24/02/22 23/02/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
28.9EUR
Average target price
34.14EUR
Spread / Average Target
+18.16%
Consensus
1st Jan change Capi.
+11.07% 68 575 M $
+14.83% 48 276 M $
-11.9% 47 195 M $
+10.27% 35 749 M $
-1.73% 35 315 M $
+13.39% 31 069 M $
+39.62% 30 186 M $
-23.62% 30 183 M $
+9.51% 29 789 M $
+15.12% 21 504 M $
Other Life & Health Insurance
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer